Literature DB >> 1833092

Studies on the measurement of protein S in plasma.

E G Bovill1, M M Landesman, S A Busch, G R Fregeau, K G Mann, R P Tracy.   

Abstract

The anticoagulant factor Protein S circulates in two major forms, free and bound to C4b binding protein (C4BP). We report a monoclonal antibody-based enzyme-linked immunosorbent assay of human Protein S that is sensitive (detection limit 30 ng) and free of notable competition from other vitamin K-dependent proteins. We demonstrate assay sensitivity to Protein S-C4BP complex, as well as to free Protein S by (a) results of immunoaffinity chromatography involving the assay antibody; (b) parallelism between the standard curve and a plasma dilution curve, including dilutions greater than 100-fold; (c) lack of effect of added C4BP on Protein S values; and (d) reactivity in the assay by high-molecular-mass plasma Protein S in gel permeation studies. These latter studies also indicate that uncomplexed Protein S has an apparent molecular mass of approximately 150,000 Da, attributable to either polymerization or conformational considerations. Inter- and intra-assay CVs were 9.8% and 5.1%, respectively, and 90% of Protein S added to plasma was recovered. Reference ranges (mean and SD) for total Protein S in middle-aged normal subjects were 16.6 (1.9) mg/L for men (n = 54) and 16.0 (3.0) mg/L for women (n = 38). In the polyethylene glycol precipitation method, the reference values for free Protein S were 5.4 (1.6) mg/L for men and 4.4 (1.1) mg/L for women.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833092

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thromholysis in Myocardial Infarction Phase II (TIMI II) Trial.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

2.  Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.

Authors:  Adrienn Teraz-Orosz; Magdalena Gierula; Anastasis Petri; David Jones; Renos Keniyopoullos; Patricia Badia Folgado; Salvatore Santamaria; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  Blood Adv       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.